Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.20+0.07 (+0.77%)
Close on Nov 17, 2026Market cap $821.53MP/E –Yield –
Syndax Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Syndax Pharmaceuticals's total debt was $344.10M at Sep 30, 2026. For fiscal 2025 it was $343.91M, down 49.1% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $343.91M | -49.1% |
| FY2024 | Dec 31, 2024 | $675.25M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $344.10M | +0.1% |
| Q2 FY2026 | Jun 30, 2026 | $344.03M | +0.1% |
| Q1 FY2026 | Mar 31, 2026 | $343.97M | +0.1% |
| Q4 FY2025 | Dec 31, 2025 | $343.91M | -49.1% |
| Q3 FY2025 | Sep 30, 2025 | $343.91M | – |
| Q2 FY2025 | Jun 30, 2025 | $343.85M | – |
| Q1 FY2025 | Mar 31, 2025 | $343.79M | – |
| Q4 FY2024 | Dec 31, 2024 | $675.25M | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
See a number that looks wrong?